Page 467 - TNFlipTest

Toronto Notes 2019 Skin Lesions General Surgery and Thoracic Surgery GS65 Skin Lesions
• seeDermatology,D5;EmergencyMedicine,ER43;PlasticSurgery,PL5 Common Medications
Antiemetics
Analgesics
DVT Prophylaxis
Antidiarrheals Laxatives
Sedatives
Antibiotics
Over-the-Counter Medications
• dimenhydrinate (Gravol®) 25-50 mg PO/IV/IM q4-6h prn
• prochlorperazine (Stemetil®) 5-10 mg PO/IV/IM bid-tid prn
• metoclopramide (Maxeran®) 10 mg IV/IM q2-3h prn, 10-15 mg PO qid (30 min before meals and qhs) • ondansetron (Zofran®) 4-8 mg PO q8h prn
• granisetron (Kytril®) 1 mg PO bid (for nausea from chemotherapy/radiation)
• acetaminophen ± codeine (Tylenol® #3/plain) 1-2 tabs q4-6h PO/PR prn
• hydromorphone i-ii tabs PO q4h prn, 0.5-2 mg IV q3-4h prn
• ibuprofen 200-400 mg PO q4-6h prn
• morphine 2.5-10 mg IM/SC q4-6h prn + 1-2 mg IV q1h prn for breakthrough • ketorolac (Toradol®) 30-60 mg IM/IV q6h prn
• acetominophen/oxycodone (Percocet® ) 325/5 mg, 1-2 tabs PO q4-6h prn
• heparin 5,000 units SC bid, if cancer patient then heparin 5,000 units SC tid • dalteparin (Fragmin®) 5,000 units SC daily
• enoxaparin (Lovenox®) 40 mg SC daily
• loperamide (Imodium®) 4 mg PO initially, then 2 mg PO after each loose stool up to 16 mg/d • diphenoxylate + atropine (Lomotil®) 2 tabs/10 mL PO qid
• sennosides (Senokot®) 1-2 tabs qhs
• docusate sodium (Colace®) 100 mg PO bid
• glycerine suppository 1 tab PR prn
• lactulose 15-30 mL PO qid prn
• milk of magnesia (MOM) 30-60 mL PO qid prn • bisacodyl (Dulcolax®)10-15 mg PO prn
• zopiclone (Imovane®) 5-7.5 mg PO qhs prn • lorazepam (Ativan®) 0.5-2 mg PO/SL qhs prn
• cefazolin (Ancef®) 1 g IV/IM on call to OR or q8h – GP except Enterococcus, GN only E. coli, Klebsiella, and Proteus
• cefalexin (Keflex®) 250-500 mg PO qid – Listeria, GP except Enterococcus, GN only E. coli, Klebsiella, and Proteus
• ceftriaxone 1-2 g IM/IV q24h – broad coverage including Pseudomonas
• ampicillin 1-2 g IV q4-6h – Listeria, GP (Enteroccus) except Streptococcus and E. coli, oral anaerobes except Bacteroides • gentamicin 3-5 mg/kg/d IM/IV divided q8h; monitor creatinine, gentamicin levels – GN including Pseudomonas
• ciprofloxacin 400 mg IV q12h, 500 mg PO bid – GN including Pseudomonas
• metronidazole (Flagyl®) 500 mg PO/IV bid (500 mg PO tid for C. difficile) – anaerobes
• clindamycin 600-900 mg IV q8h, 150-400 mg PO qid – GP except Enterococcus, anaerobes • piperacillin/tazobactam 4.5 mg IV q6h – GP, GN, and anaerobes
• vancomycin 1g IV q12h – GP and MRSA
• sulfamethoxazole/trimethoprim DS (Septra®) PO bid – GP, GN including Nocardia
• bismuth subsalicylate (Pepto-Bismol®) 2 tabs or 30 mL PO q30min-1h up to 8 doses/d side effects: black stools, risk of Reye’s syndrome in children
• ASA + citrate + bicarbonate (Alka-Seltzer®) 2 tabs in 4 oz water PO q4h prn, max 8 tabs
• aluminum hydroxide + magnesium hydroxide (Maalox®) 10-20 mL or 1-4 tabs PO prn
• calcium carbonate (Tums®) 1-3 g PO q2h prn
• calcium carbonate and magnesium hydroxide (Rolaids®) 2-4 tabs PO q1h prn, max 12 tabs/d
References
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2001;253:1082-1093.
Amato B, Moja L, Panico S, et al. Shouldice technique versus other open techniques for inguinal hernia repair. Cochrane DB Syst Rev 2012;4:CD001543.
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.
Andrén-Sandberg A. Diagnosis and management of gallbladder cancer. N Am J Med Sci 2012;4:293-299.
Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009;7:47-52.
Applegate KE. Intussusception in children: evidence-based diagnosis and treatment. Pediatr Radiol 2009;39(Suppl 2):S140-143.
Arnold DT, Reed JB, Burt K. Evaluation and management of the incidental adrenal mass. Proc (Bayl Univ Med Cent) 2003;16:7-12.
Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-400.
Bazarah BM, Peltekian KM, McAlister VC, et al. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Clin Invest Med 2004;27:162-167.
Bhangu A, Singh P, Lundy J, et al. Systemic review and meta-analysis of randomized clinical trials comparing primary vs. delayed primary skin closure in contaminated and dirty abdominal incisions. JAMA Surg 2013;148:779-786. Bland KI. The practice of general surgery, 1st ed. Toronto: WB Saunders, 2002.
Blay J-Y, Mehren MV, Blackstein ME. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer 2010;116:5126-5137.
Brandt ML. Pediatric hernias. Surg Clin N Am 2008;88:27-43,vii-viii.
Brunicardi FC, Andersen D, Billiar T, et al. Schwartz’s principles of surgery, 9th ed. McGraw-Hill, 2010.
Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2017. Toronto, ON: Canadian Cancer Society; 2017.
Canadian Task Force on Preventive Health Care. Colorectal cancer screening. CMAJ 2001;165:206-208.
Carmichael JC, Keller DS, Baldini G et al. Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum 2017;60:761-784.
Chandler CF, Lane JS, Fergusoan P, et al. Prospective evaluation of early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Am J Surg 2000;66:896-900.
Cholongitas E, Burroughs AK. The evolution in the prioritization for liver transplantation. Ann Gastroenterol 2012;25:6-13.
Coccolini F, Nardi M, Montori G et al. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg 2018; 51:120-127.
Coha M, Cerutti E, Schellino MM, et al. Piedmont Intensive Care Units Network (PICUN). Continuous positive airway pressure for treatment of post-operative hypoxemia: a randomized controlled trial. JAMA 2005;293:589-595.
Colquitt JL, Pickett K, Loveman et al. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014;(8):CD003641.